WKL Wolters Kluwer NV

Wolters Kluwer, Omnicell Partnership Delivers First Integrated IV Sterile Compounding Solution Covering the Full Quality Spectrum of Pharmacy Workflow and Compliance

Wolters Kluwer Health today announced a partnership with Omnicell, Inc. to distribute Omnicell’s IVX Workflow system, which integrates with Wolters Kluwer’s market-leading Simplifi 797®. The partnership enables customers to easily acquire and deploy integrated automation and quality tools together to improve accuracy, enhance safety and facilitate compliance with IV compounding best practices.

“Today’s healthcare organizations face unprecedented pressure to achieve a higher standard of sterile compounding practice and are seeking a comprehensive approach to quality and compliance,” said David A. Del Toro, President and CEO of Clinical Software Solutions at Wolters Kluwer. “We are pleased to integrate Simplifi 797 with Omnicell’s next-generation workflow technology and distribute these together as one solution to ensure sterile compounding environments have all the best practice tools and resources needed to meet USP <797> and USP <800> compliance standards, elevate staff competencies and keep patients safe.”

Pharmacists use the integrated IVX Workflow system to customize and design risk-based IV workflows for different compounding applications and remain fully compliant with USP <797> and USP <800>. This enhances compounding workflows by equipping pharmacists with integrated barcode scanning, gravimetric or volumetric verifications, advanced image recognition, photo documentation and label printing—all within a single compact package designed for easy placement within laminar airflow hoods or isolators.

“The integration with Simplifi 797 further elevates safety and compliance by providing the expert content needed to align with complex USP guidelines, including risk management and quality assurance practices, comprehensive policies and procedures, staff training and evaluations and robust reporting,” said Rob Seim, President of Global Automation and Medication Adherence at Omnicell, Inc. “We are thrilled to have our new IV workflow solution integrated with this market-leading quality management and compliance software.”

Wolters Kluwer will demonstrate the integrated IVX Workflow system in Booth #1633 at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, taking place December 2-7 in Orlando. For more information, click here.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

For more information about Wolters Kluwer’s solutions and organization, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

OMCL-G

EN
01/12/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details February 27 – March 4, 2026

Share Buyback Transaction Details February 27 – March 4, 2026 PRESS RELEASE                                         Share Buyback Transaction Details February 27 – March 4, 2026 Alphen aan den Rijn – March 5, 2026 - Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 80,106 of its own ordinary shares in the period from February 27, 2026, up to and including March 4, 2026, for €5.5 million and at an average share price of €68.11. Included is a block trade of 61,336 ordinary shares for €4.0 mill...

Guy Sips ... (+10)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update March 2026: Removing Aedifica – Adding Pr...

The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continue into 2027. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. The highly anticipated AI productivity gains also will have to transpire sooner or later or a US market correction becomes unavoidable. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We...

 PRESS RELEASE

Wolters Kluwer recognized as one of America’s Best Large Employers for...

Wolters Kluwer recognized as one of America’s Best Large Employers for the sixth consecutive year PRESS RELEASE Wolters Kluwer recognized as one of America’s Best Large Employers for the sixth consecutive year Recognition highlights Wolters Kluwer’s strength in top talent and engineering capabilities critical to delivering AI‑powered solutions for customers Alphen aan den Rijn — March 3, 2026 — , global leader in professional information solutions, software, and services, has once again been named among , marking the sixth consecutive year the company has earned a place on the prestigiou...

Wolters Kluwers: 2 directors

Three Directors at Wolters Kluwers bought/sold after exercising options/maiden bought 5,521 shares at between 64.120EUR and 64.790EUR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...

 PRESS RELEASE

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwe...

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer PRESS RELEASE Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer New CEO prioritizes AI investment, partnerships, and go-to-market Alphen aan den Rijn — February 27, 2026 — , a global leader in information solutions, software and services, announced that has officially assumed the role of Chief Executive Officer, succeeding Nancy McKinstry. Caywood brings a strong track record of transforming and growing businesses at Wolters Kluwer through investment in innovation, portfolio management, and c...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch